If you enjoyed reading this article from Tom Winnifrith
You can stop at any time.
This website will always remain free but if you enjoy its varied and controversial comment feel free to assist
with our running costs and to show your appreciation with a one off or regular donation. In advance, I thank you, Tom Winnifrith
I have had enough of scumbags on the London small cap scene for today and especially of Stuart Ashman of Skinbiotherapeutics (SBTX). With two new revelations I explain why I am out.